EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants 15.01.2025 / 15:21 CET/CEST The issuer is solely ...
Mainstay Medical Holdings plc today announced the publication of positive one-year primary assessment results of the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable ...
A University of Sydney study has found that integrating lifestyle support into chronic back pain treatment helps reduce disability and improves quality of life.